MetLife stock trades steadily as earnings and dividend support valuation
Published on 07/24/2026 at 07:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
MetLife Inc. (ISIN US59156R1086) stock remains anchored by earnings power and regular capital returns, reflecting the financial profile of one of the largest life insurers in the United States. As of 16 May 2024, according to a Nasdaq quote overview, MetLife stock closed near $71 on the New York Stock Exchange, positioning the company at a market capitalization of roughly $52 billion in USD terms. For retail investors, the earnings trajectory and dividend yield are central to how MetLife stock fits into an income and value portfolio.
Revenue up over 10 percent
MetLife Inc. operates through several segments including U.S., Asia, Latin America, and Europe, Middle East and Africa, with group-wide financials revealing the scale of its insurance and retirement solutions business. In its full-year 2023 financial information, MetLife reported total revenues of around $69.9 billion, compared with approximately $64.5 billion in 2022, implying year-over-year growth of about 8.4 percent. This expansion was driven by higher premiums, net investment income, and fee revenues tied to retirement and asset management activities, underlining that the top line is still growing despite a mature business footprint.
Within that 2023 revenue figure, a meaningful component came from premiums and fees associated with life, accident, and health coverage, annuities, and pension risk transfer solutions. These insurance and retirement products generate predictable cash flows, which can be sensitive to interest rates and capital market conditions but also create long-term customer relationships. For investors analyzing MetLife stock, the revenue growth compared with 2022 is a key quantified comparison that shows the insurer expanded its business by several billion dollars, even as it navigated regulatory and macroeconomic changes.
Earnings and EPS trends in 2023
Looking at profitability, MetLife’s 2023 net income available to common shareholders reached roughly $3.0 billion, according to its annual report figures, versus about $2.4 billion in 2022. That implies an increase of approximately 25 percent year over year, signaling that the company converted higher revenues and investment income into stronger bottom-line results. On a per-share basis, MetLife reported diluted earnings per share for 2023 in the area of $3.90, compared with approximately $3.10 in 2022, again illustrating growth in earnings that supports valuation metrics such as the price-to-earnings ratio applied to MetLife stock.
Adjusted earnings, a non-GAAP measure often used by insurance analysts to strip out one-off items, also showed improvement over the prior year. This adjusted profitability reflected the performance of core insurance operations, including mortality, morbidity, and expense results, as well as the contribution from investment portfolios. For a retail investor, the EPS increase from roughly $3.10 to $3.90 over one year is a concrete numerical comparison that helps frame MetLife’s earnings momentum and explains why the stock’s multiple can remain stable even when interest rate expectations shift.
Dividend of more than two dollars per share
MetLife has a long track record of paying dividends, which plays a central role in the investment case for MetLife stock. In 2023, the company distributed total common stock dividends of around $2.08 per share, up from roughly $1.86 per share in 2022, according to its shareholder information. That represents a year-over-year increase of about 11.8 percent in the annual dividend, underscoring management’s confidence in the durability of cash flows and capital position. At a share price near $71 as of mid May 2024, the trailing dividend yield would be close to 2.9 percent, offering income-focused investors a combination of payout and potential capital appreciation.
Dividend payments are supported by MetLife’s risk-based capital ratios and regulatory oversight, as well as its ongoing ability to generate free cash flow after claim payments, operating expenses, and investment in growth initiatives. The dividend track record also signals that the insurer aims to return a portion of its earnings to shareholders while still retaining capital to support new business and manage volatility in claims and investment markets. For investors comparing MetLife stock with peers in the insurance sector, the step-up in dividend per share from 2022 to 2023 is a quantified sign of shareholder distribution discipline.
Capital management and buybacks
Beyond dividends, MetLife has been active in share repurchases, which directly influence the share count and can support earnings per share. In 2023, according to its capital management disclosures, the company returned over $4 billion to common shareholders through a combination of dividends and buybacks. That package included substantial share repurchase activity, reducing the number of shares outstanding and concentrating earnings among remaining shareholders. Such actions often provide a tailwind to EPS growth, as the numerator (earnings) rises while the denominator (shares) falls or remains stable.
This capital return is facilitated by MetLife’s ability to maintain strong statutory capital across its insurance entities, meeting regulatory requirements while still having flexibility to use excess capital. In addition to buybacks, MetLife deploys capital into new products, distribution channels, and technology investments, aiming to improve underwriting, pricing, and customer experience. For retail investors, the blend of cash dividends and buybacks is important because it reflects MetLife’s priorities in using free cash flow: balancing growth, resilience, and direct shareholder returns, all of which can have implications for how MetLife stock performs over a multi-year horizon.
Segment performance and geographic mix
MetLife’s revenue and earnings are diversified across segments, which influences the risk profile of MetLife stock. The U.S. segment contributes a substantial portion of adjusted earnings, driven by group benefits, retirement and income solutions, and individual life products. In 2023, MetLife’s U.S. segment produced several billion dollars of adjusted earnings, with stable margins supported by pricing discipline and claims management. The Asia segment, meanwhile, continued to deliver growth in premiums and policy counts, benefiting from rising middle-class demand for life and health protection.
Latin America and EMEA segments add further diversification, although currency and regulatory factors can introduce volatility. In 2023, these regions contributed meaningfully to total revenues, with growth in certain markets offsetting weaker performance in others. From an investor perspective, the geographic mix means that macroeconomic changes in one region may be cushioned by stability in another, dampening earnings variability at the group level. Such diversification is a structural reason why some investors view MetLife stock as a core holding within financials rather than a concentrated regional risk.
Interest rates, investment income, and spreads
Interest rates and investment spreads are critical drivers of MetLife’s financial results, and by extension, of the performance of MetLife stock. As rates rose across 2022 and 2023, MetLife benefited from higher yields on new money investments and reinvestments, lifting net investment income. In 2023, net investment income contributed tens of billions of dollars to revenue, with higher yields partly offset by unrealized losses in available-for-sale portfolios. The spread between investment returns and policyholder crediting rates influences profitability in annuity and retirement products, so the interest rate environment is a constant focus in MetLife’s risk management.
Higher rates also affect the valuation of liabilities and the mark-to-market of certain assets, which can create volatility in reported GAAP earnings. However, MetLife’s long-duration liabilities and asset-liability management strategies are designed to match cash flows and reduce sensitivity to short-term rate moves. For investors, the impact of interest rates becomes visible through reported net investment income and other comprehensive income, which may cause swings in book value. Understanding this relationship helps explain why MetLife stock can react to changes in Federal Reserve policy and bond market expectations even when insurance underwriting results remain stable.
Guidance and outlook for 2024
In its messaging around the end of 2023 and early 2024, MetLife provided guidance ranges and qualitative outlook comments about expected trends in premiums, expenses, and investment income. The company indicated that it anticipated continued growth in certain products such as group benefits and pension risk transfer solutions, while also planning to manage expenses to protect margins. Although exact guidance figures can vary by segment, the overall tone suggested a focus on steady earnings growth and disciplined capital deployment, rather than aggressive expansion or high-risk strategies.
Furthermore, MetLife commented on regulatory developments and accounting changes, including the adoption of Long-Duration Targeted Improvements for insurance contracts, which affects how reserves and earnings are reported. For investors, these changes matter because they influence reported numbers and comparability across time periods, and can therefore affect how MetLife stock is valued relative to peers. Clear guidance and explanations help market participants adjust their models and maintain confidence in the insurer’s financial reporting.
Product focus on group benefits
A central product line for MetLife is group benefits, including employer-sponsored life, dental, disability, and other coverages. Group benefits generated billions of dollars in revenues in 2023, reflecting the company’s strong position as a provider to large employers and institutions. The scale of this business segment creates economies in distribution and underwriting, and the recurring nature of premiums supports a stable revenue stream that adds resilience to MetLife’s overall portfolio.
Demand for group benefits tends to track employment trends and corporate benefits budgets, which can be influenced by economic cycles. However, large employers often view benefits as critical to talent attraction and retention, cushioning the impact of downturns. For MetLife stock, the prominence of group benefits in the product mix signals that a significant share of revenues is tied to institutional relationships rather than purely individual retail insurance sales. This has implications for how analysts assess the stickiness of revenues and the competitive landscape, given that MetLife competes with other large insurers for these contracts.
MetLife stock and income profile
For retail investors, MetLife stock offers a combination of earnings exposure to the life and health insurance sector and a steady income stream through dividends. With 2023 earnings per share around $3.90 and an annual dividend per share near $2.08, MetLife’s payout ratio sits in a range that leaves room for reinvestment while still returning a material portion of profits to shareholders. The EPS growth compared with 2022 supports an argument that the current dividend is covered by underlying profitability, even though future claim trends and investment results must be monitored.
At a share price close to $71 as of 16 May 2024, the valuation multiple relative to trailing earnings and the dividend yield suggests MetLife stock occupies a middle ground between high-growth financials and more defensive income vehicles. Investors analyzing the stock often compare its valuation and yield with other insurers and financials, as well as with bond yields, to decide how it fits within diversified portfolios. While no single metric can capture the full risk-reward profile, the concrete numbers on revenue, earnings, and dividends provide a foundation for that comparison.
Closing view on MetLife stock price
As of 16 May 2024, MetLife stock traded around $71 per share on the New York Stock Exchange, according to a Nasdaq summary quote, with a market capitalization near $52 billion in USD terms. That price level sits within a broader 52-week range that has reflected shifts in interest rates, earnings releases, and sector sentiment. For investors monitoring MetLife stock, the combination of 2023 revenue of approximately $69.9 billion, net income of about $3.0 billion, and an annual dividend per share near $2.08 provides concrete, dated metrics for assessing whether the current valuation aligns with their risk and return preferences.
MetLife stock key data
- Company: MetLife Inc.
- ISIN: US59156R1086
- Ticker: NYSE: MET
- Trading venue: NYSE
- Price (as of 16 May 2024, 16:00 ET): 71.00 USD
- Market capitalization: 52,000,000,000 USD (as of 16 May 2024)
- Sector / Industry: Financials / Insurance
- Index membership: S&P 500
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
